|
|
Willem J. Remme MD,
PhD, FESC, FACC, FAHA, is currently the Chairman and CEO of Sticares InterACT and Director
of the Sticares Cardiovascular Research Institute in Rhoon, the
Netherlands.
Professor Remme has been Director of the Sticares
Cardiovascular Research Institute since 1981, mainly involved in phase
II-III clinical cardiovascular and metabolic trials and in basic research.
In 2000 Professor
Remme became CEO of Sticares InterACT, a full service CRO operating
globally. He is also the first Chairman of a new global academic CRO
group, GlobalACT.
|
Professor Remme has served as an Associate Professor at the University of
Groningen, the Netherlands, Visiting Associate Professor of Medicine at the
Harvard Medical School and as Visiting Research Professor of Medicine at the
University of Arizona. In 2001 he became Honorary Professor of Cardiology at
the “Carol Davila” University of Medicine in Bucharest, Romania.
He has served on Editorial Boards including: Cardiology (Section Head –
Clinical Pharmacology), Cardiovascular Drugs and Therapy, Journal of Cardiac
Failure, Heart Failure Reviews, Dialogues in Cardiovascular Medicine, and the
European Journal of Heart Failure and was Journal Editor to Advances in
Cardiology. Currently, he is Editor-in-Chief of Cardiovascular Drugs and
Therapy.
He is a Fellow of the American College of Cardiology, the American Heart
Association and the European Society of Cardiology. Professor Remme was the
initiator and first Chairman of the Working Group on Heart Failure of the ESC.
He served as Chairman of the Task Force Guidelines for the Treatment of Heart
Failure of the ESC in 1997 and as Co-Chairman in 2001. In 1997, he became
President of the International Society of Cardiovascular Pharmacotherapy and
Member of the Council on Clinical Cardiology of the World Heart Federation and
in 1998 became Chairman of the European Educational Program in Cardiology of
the ESC. In 2004 he initiated and became the first President of the World Heart
Failure Society.
Professor Remme is an Honorary Member of the Société Cardiologique
Française, the Romanian Society of Cardiology and the Romanian Society of
Internal Medicine. His major research interests are in the field of heart
failure and ischemic heart disease, serving as Chairman or member of Steering,
Critical Events Committees and Data Safety Monitoring Boards of large trials
including: EUROPA, CIBIS I and II, RALES I and II, COMET, CARMEN, CAPRICORN,
EPHESUS, PREAMI, SHIFT and EMPHASIS-HF. In addition, he is the initiator and
Chairman of a pan-European heart failure awareness and perception survey
program (SHAPE) as well as a global heart failure awareness survey GAPS-HF.
|
